Abstract: Provided is a back cover. The back cover includes a body, a movable member, and a first to-be-sensed member. The body includes a notch. The movable member is movably disposed on the body. The first to-be-sensed member is disposed on the movable member. When the movable member is located in a first position relative to the body, a projection of the movable member onto the body is located outside the notch. When the movable member moves to a second position relative to the body, the movable member covers at least part of the notch. Further provided is an electronic assembly having the foregoing back cover. The movable member of the back cover is movable relative to the body, to be located outside the notch or cover at least part of the notch. When the back cover is applied on the electronic device, the movable member is configured to stop an image acquisition assembly of the electronic device to prevent the image acquisition assembly from being accidentally thrown out.

Abstract: A fully human antibody targeting GPRC5D and a chimeric antigen receptor (CAR) comprising the fully human antibody. A host cell expressing the CAR, such as a CAR-T cell. A use of the fully human antibody, the CAR, and the CAR-T cell in treatment of tumors (such as multiple myeloma).

Abstract: Provided is a fully human single-domain tandem chimeric antigen receptor (CAR) capable of specifically binding to a CD5 protein, which comprises a CD5 binding domain, a transmembrane domain, a co-stimulatory domain and an intracellular signaling domain. Also provided are engineered immune effector cells, such as T cells, comprising the chimeric antigen receptor, and use of the CAR and the engineered immune effector cells in the treatment of diseases or conditions associated with the expression of CD5.

Abstract: The present application provides an anti-CD5 antibody. The present application further provides a chimeric antigen receptor (CAR) that specifically binds to a CD5 protein, which comprises a CD5 binding domain, a transmembrane domain, a co-stimulatory domain and an intracellular signaling domain. Further provided are engineered immune effector cells (such as T-cells) comprising the chimeric antigen receptor. The present application further provides use of the CAR and the engineered immune effector cells in the treatment of diseases or conditions associated with the expression of CD5.

Abstract: Provided is a back cover. The back cover includes a body, a movable member, and a first to-be-sensed member. The body includes a notch. The movable member is movably disposed on the body. The first to-be-sensed member is disposed on the movable member. When the movable member is located in a first position relative to the body, a projection of the movable member onto the body is located outside the notch. When the movable member moves to a second position relative to the body, the movable member covers at least part of the notch. Further provided is an electronic assembly having the foregoing back cover. The movable member of the back cover is movable relative to the body, to be located outside the notch or cover at least part of the notch. When the back cover is applied on the electronic device, the movable member is configured to stop an image acquisition assembly of the electronic device to prevent the image acquisition assembly from being accidentally thrown out.

Abstract: The present invention relates to a pharmaceutical composition for treating hepatitis, liver fibrosis, and liver cancer, which comprises the following components in parts by weight: 0.15-10 parts of vinegar-baked bupleurum root polysaccharides or bupleurum root polysaccharides and 0.05-5 parts of a drug for treating hepatitis.

Abstract: The present invention relates to a pharmaceutical composition for treating hepatitis, liver fibrosis, and liver cancer, which comprises the following components in parts by weight: 0.15-10 parts of vinegar-baked bupleurum root polysaccharides or bupleurum root polysaccharides and 0.05-5 parts of a drug for treating hepatitis.

Abstract: The invention relates to a low-noise gas instantaneous water heater, belonging to the technical field of gas appliances. The low-noise gas instantaneous water heater comprises a combustion device, a heat exchanger and a blower; wherein the combustion device, the heat exchanger and the blower are arranged such that a combustion flue gas is discharged after passing sequentially through the heat exchanger and the blower; the blower comprises a stepless speed regulating motor with a motor control panel and an impeller driven by the motor, and at least one thermal insulation device is arranged between the motor control panel and the combustion flue gas generated by the combustion device.

Abstract: The invention relates to a low-noise gas instantaneous water heater, belonging to the technical field of gas appliances. The low-noise gas instantaneous water heater comprises a combustion device, a heat exchanger and a blower; wherein the combustion device, the heat exchanger and the blower are arranged such that a combustion flue gas is discharged after passing sequentially through the heat exchanger and the blower; the blower comprises a stepless speed regulating motor with a motor control panel and an impeller driven by the motor, and at least one thermal insulation device is arranged between the motor control panel and the combustion flue gas generated by the combustion device.

Abstract: The present invention provides a method for transdermal delivery of molecules. The method comprises the application of electrical pulses concurrently or sequentially with application of the molecules and a lipid composition comprising negatively charged liposomal compositions. The application of the liposomal components enhances permeability of the target site for delivery of the molecule even though the molecules are not encapsulated in the liposomal components.

Abstract: In order to increase channel capacity of a processing engine in a telecommunication network, separate telecommunication signals are multiplexed in pairs to produce at least one multiplexed signal. This signal is transmitted to the processing engine to create a processed multiplexed signal. The processed multiplexed signal from the processing engine is then demultiplexed to produce separate processed telecommunication signals.

Abstract: A method of reducing peak-to-average ratio in multi-carrier communications systems, involves extracting sign bits from a data stream for each sub-carrier; scrambling the sign bits; recombining the scrambled sign bits with a remaining portion of the incoming data stream to form a transmission data stream; modulating the transmission data stream; transmitting the modulated transmission data stream over a transmission medium; receiving the modulated transmission data stream; extracting the scrambled sign bits from the received transmission data stream; unscrambling the scrambled sign bits; recombining the scrambled sign bits with a remaining portion of the received transmission data stream to form a received data stream; and demodulating the received data stream.

Abstract: Methods and compositions for the efficient transformation of sorghum is provided. The method involves infection with Agrobacterium, particularly those comprising a super-binary vector. In this manner, any gene of interest can be introduced into the sorghum plant. The transformed gene will be flanked by at least one T-DNA border and present in the transformed sorghum in low copy number. Transformed sorghum, cells, tissues, plants, and seed are also provided. The invention encompasses regenerated, fertile sorghum plants, transgenic seeds produced therefrom, T1 and subsequent generations.